An interventional study of INVOS 5100 in HYPERNATREMIA, sponsored by Zekai Tahir Burak Women's Health Research and Education Hospital. Status unknown at 1 site in Turkey. Open to participants aged 1 Day to 1 Month. Per ClinicalTrials.gov, last updated 2011-02-18.
Sponsored by Zekai Tahir Burak Women's Health Research and Education Hospital · Not applicable, Interventional, and Screening
The aim of the study is to evaluate cerebral oxygenation with Near infrared spectrophotometry (NIRS) at the hypernatremic dehydration in newborns.
Exclusion Criteria:
Device: INVOS 5100
INVOS 5100 IS AN EQUIPMENT THAT MEASURED CEREBRAL OXYGENATION WITH NEAR INFRARED SPECTROPHOTOMETRY METHOD.
CEREBRAL OXYGENATION
NIRS METHODS
Time frame: 3 MONTHS
NEURODEVELOPMENT
NEURODEVELOPMENT EVALUATION
Time frame: 12-18 MONTHS
This study is status unknown, as verified in Feb 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zekai Tahir Burak Women's Health Research and Education Hospital